The Journal of Clinical Endocrinology & Metabolism · 2000 · 100 citations · 56 references
Life SciencesBiochemistryObstetricsLipid BiochemistryMaternal NutritionMaternal-fetal MedicineLipoprotein AnalysisLipoprotein MetabolismMaternal-fetal PhysiologyPregnancyPregnancy PhysiologyTriglyceride MetabolismApolipoprotein B-containing LipoproteinsHigh-density Lipoprotein MetabolismLipoprotein Metabolism RegulationLipoprotein Subfraction ProfilingLow-density Lipoprotein ParticlesMaternal Lipid MetabolismTriglyceride-rich LipoproteinsVery Low-density Lipoprotein Metabolism
Pregnancy is accompanied by changes in the maternal lipoprotein metabolism that may serve to satisfy the nutritional demands of the fetus. In this study lipoprotein metabolism was investigated in 23 women during normal pregnancy in the first, second, and third trimesters and in 15 healthy nonpregnant women with regular menstrual cycles. Lipid and apolipoprotein concentrations were measured in total plasma, very low density, intermediate density, low density (LDL), and high density lipoproteins, and in each of six LDL subfractions. During early pregnancy, triglycerides, and dense LDL were higher than in the nonpregnant state. With advancing gestation, triglycerides increased and the distribution of apolipoprotein B-100-containing lipoproteins became increasingly dominated by the accumulation of very low density and intermediate density lipoproteins and buoyant, triglyceride-rich LDL. This is the first study that investigates LDL subfractions in pregnancy using a method that strictly separates LDL subfractions by virtue of density. The accumulation of buoyant, triglyceride-rich lipoproteins may be related to the down-regulation of maternal lipase activities by placental hormones. As a consequence, the metabolic changes of late pregnancy may result in an increased flux of lipoprotein-derived lipids to the placenta, which, with advancing gestation, increasingly expresses receptors with a high affinity for triglyceride-rich lipoproteins.
56
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Melissa A. Austin · JAMA · 1988 · 1.7K citations
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
M A Austin, Mary‐Claire King, K M Vranizan et al. · Circulation · 1990 · 1.4K citations · Full text
Bruce A. Griffin, Dilys J. Freeman, Graeme W. Tait et al. · Atherosclerosis · 1994 · 531 citations